SAN DIEGO–(BUSINESS WIRE)– #ELANE–Onchilles Pharma Doses First Patient in Phase 1/2 Clinical Trial of N17350 for Advanced Solid Tumors
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Onchilles Pharma Doses First Patient in Phase 1/2 Clinical Trial of N17350 for Advanced Solid Tumors
